Don't Miss Out! Top Stories from The Juice - 5/19

ICYMI: We've got you covered. Here is a roundup of the top stories from last week before we get to the week ahead. [View in browser]( BROUGHT TO YOU BY: ICYMI: We've got you covered. Here is a roundup of the top stories from last week before we get to the week ahead. [Should You Hold Apple (AAPL)?]( Apple (AAPL) needed to prove itself in its latest earnings report. A lack of new products and a slowdown in China hampered sales over the past year when revenues declined for the first time since 2019. Thankfully, earnings beat expectations while Apple hyped its soon-to-be-released iPad Pro, which is... [Read More]( [The ETF Every Long-Term Investor Should Consider]( Thanks for joining us. And please forward today’s Juice to a friend and tell them they can sign up to receive our newsletter for free at this link. The other day in The Juice, we suggested taking a long hard look at small cap stocks via the most popular small cap ETF, the iShares Russell 2000 ETF (IWM).... [Read More]( [Forget Market Fears, Focus on the Future]( While the market dances to the tune of uncertainty, AI stands firm, shaping the world's technological horizon. With Tesla, Ford, and GM pouring billions into AI, the sector's growth is unstoppable. Learn how to separate the winners from the pretenders with The Motley Fool's exclusive AI investment report. Our picks, including Netflix and Tesla, have seen astronomical gains. Invest boldly for just $.27/day..... [Unlock Your Potential]( Sponsored [The 5 Most Popular Small Cap Growth ETFs]( In The Most Popular ETF The Juice Never Talks About, we explained that small cap stocks might be about to have their day, particularly if the landscape shifts away — even a little — from tech stocks. If you think this will happen over the near- to longer-term, one way to play it is by going equal... [Read More]( [This 10.5% MONTHLY payer could add on double-digit gains in 2024]( One of my favorite income plays right now is an under-the-radar fund that pays an incredible 10.5% monthly dividend. I'm so excited about this fund that I've made it a core holding in my "8% Monthly Payer" portfolio - an easy-to-buy collection of stocks and funds that could hand you $3,330+ in dividend payouts every single month!.... [Click here to learn more.]( Sponsored [The Most Popular Pharmaceuticals ETFs]( As was most recently the case with smart-beta dividend ETFs and artificial intelligence ETFs, it’s almost always instructive to conduct this exercise. A look at the recent and longer-term performance of the four most popular pharma ETFs in Trackstar raises a question. ETF YTD 1-year 5-year iShares... [Read More]( [We want to hear from you! Let us know your thoughts by clicking here]( [InvestingChannel Logo](#) Follow us on: [Facebook Logo]( [LinkedIn Logo]( [Twitter Logo]( [Instagram Logo]( To ensure delivery of all emails, [allow us on your list](. Manage your subscriptions with our [preference center](. [Unsubscribe here.]( View our privacy policy [here](. Copyright ©2024 InvestingChannel. All rights reserved. 1325 Avenue of the Americas, Floor 27 & 28 New York, New York 10019 Disclaimer: This is not investment advice. This InvestingChannel, Inc., newsletter is for information purposes only and is based on opinion. Futures, forex, stock, and options trading are not appropriate for all investors. There is a substantial risk of loss associated with trading these markets. Losses can and will occur. No system or methodology has ever been developed that can ensure returns or eliminate losses. InvestingChannel, Inc., makes no representation or implication that using any of the methodologies or systems in this newsletter will generate returns or insure against losses. Investors should be cautious about any and all investments and are advised to conduct their own due diligence prior to making any investment decisions. [Link](